Five Prime Thera (FPRX) Stock News

NASDAQ:FPRX -

38

+0.01 (+0.03%)

Last: 4/15/2021, 8:00:00 PM

38

0 (0%)

After Hours: 4/15/2021, 8:00:00 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

FPRX Latest News, Press Relases and Analysis

All

Press Releases

4 years ago - By: Amgen - Mentions: AMGN

Amgen Successfully Completes Acquisition Of Five Prime Therapeutics

4 years ago - By: Benzinga

Earnings Outlook for Five Prime Therapeutics

4 years ago - By: The Motley Fool - Mentions: AMGN

Is Amgen's Acquisition of Five Prime a Good Move for the Big Biotech?

4 years ago - By: Barron's - Mentions: BNFT AMGN NCMI PRSP

Benefitfocus and Five Prime Therapeutics See Analyst Action

4 years ago - By: Benzinga - Mentions: AMGN

Though Potential Bidders Moved Away, Amgen's Bid For Five Prime Outlasted 15 Suitors

4 years ago - By: Kahn Swick & Foti, LLC

FIVE PRIME INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Five Prime Therapeutics - FPRX

4 years ago - By: Five Prime Therapeutics, Inc.

Five Prime Cancels Fourth Quarter and Full-Year 2020 Financial Results Conference Call

4 years ago - By: Monteverde & Associates PC

SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of Five Prime Therapeutics, Inc. - FPRX

5 years ago - By: Barron's - Mentions: AMGN COMP BMY

Amgen Acquires a Cancer Drug. Expect More Deals.

5 years ago - By: WeissLaw LLP - Mentions: AMGN

SHAREHOLDER ALERT: WeissLaw LLP Investigates Five Prime Therapeutics, Inc.

5 years ago - By: Ademi LLP

Shareholder Alert: Ademi LLP Investigates whether Five Prime Therapeutics has obtained a Fair Price in its transaction with Amgen

5 years ago - By: The Motley Fool - Mentions: AMGN

Amgen to Buy Oncology Start-Up Five Prime Therapeutics for $1.9 Billion